Sofosbuvir-based regimen is safe and effective for hepatitis C infected patients with stage 4–5 chronic kidney disease: a systematic review and meta-analysis

被引：0

作者：

Mingshu Li

Jun Chen

Zhixiong Fang

Yi Li

Qian Lin

机构：

[1] Central South University,Xiangya School of Public Health

[2] Gilead Science,Medical Affairs Department

[3] The Third People’s Hospital of Shenzhen,Department of Liver Diseases

[4] XiangTan City Central Hospital,Department of Infectious Disease

[5] The Second Xiangya Hospital of Central South University,Department of Infectious Disease

来源：

Virology Journal | / 16卷

关键词：

HCV infection; Stage 4–5 chronic kidney disease; Sofosbuvir; Dose; Meta-analysis;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

引用

共 250 条

[41]

Puoti M(undefined)undefined undefined undefined undefined-undefined

[42]

Romero-Gomez M(undefined)undefined undefined undefined undefined-undefined

[43]

Zarski JP(undefined)undefined undefined undefined undefined-undefined

[44]

Agarwal K(undefined)undefined undefined undefined undefined-undefined

[45]

Buggisch P(undefined)undefined undefined undefined undefined-undefined

[46]

Feld JJ(undefined)undefined undefined undefined undefined-undefined

[47]

Jacobson IM(undefined)undefined undefined undefined undefined-undefined

[48]

Hezode C(undefined)undefined undefined undefined undefined-undefined

[49]

Asselah T(undefined)undefined undefined undefined undefined-undefined

[50]

Ruane PJ(undefined)undefined undefined undefined undefined-undefined